Brainstorm Cell Therapeutics Faces Potential Delisting from NASDAQ due to Market Value Compliance Issue
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) recently disclosed in a Form 8-K filing with the Securities and Exchange Commission the precarious situation it faces with the Nasdaq Stock Market, LLC (Nasdaq), regarding its non-compliance with market value listing requirements. As revealed in the company’s prior Current Report on Form 8-K from July 19, 2024, Brainstorm […]
More Stories
Dream Industrial Real Estate Invest Trst (TSE:DIR.UN) Price Target Lowered to C$14.50 at Raymond James
Dream Industrial Real Estate Invest Trst (TSE:DIR.UN – Free Report) had its price target lowered by Raymond James from C$15.75...
Stifel Nicolaus Issues Pessimistic Forecast for Algoma Steel Group (TSE:ASTL) Stock Price
Algoma Steel Group (TSE:ASTL – Free Report) had its target price lowered by Stifel Nicolaus from C$22.00 to C$21.00 in...
StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)
StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report released on Monday morning. The brokerage...
Symbolic Logic (NASDAQ:EVOL) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of Symbolic Logic (NASDAQ:EVOL – Free Report) in a report released on Monday morning. The...
Cantaloupe (NASDAQ:USAT) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Cantaloupe (NASDAQ:USAT – Free Report) in a research note issued to investors on Monday....
Retail Opportunity Investments (NASDAQ:ROIC) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Retail Opportunity Investments (NASDAQ:ROIC – Free Report) in a research report sent to investors...